Prediction of 18F-FES-PET/CT Parameters on Palbociclib Combined With ET
NCT04992156
·
clinicaltrials.gov ↗
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Breast Cancer
Interventions
DRUG:
Palbociclib
Sponsor
Fudan University